This inventor holds 5 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Nanomab Technology Limited. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Innovations by Inventor Chung Lim Wong in Cancer Treatment
Introduction
Chung Lim Wong, an inventive mind based in Shanghai, China, has made significant contributions to the field of cancer treatment through his groundbreaking patents. With a total of five patents to his name, Wong's work focuses on enhancing the diagnosis and treatment of tumors, particularly those associated with the human epidermal growth factor receptor-2 (Her2/ERBB2).
Latest Patents
Two of Wong's most recent patents are noteworthy for their innovative approach to cancer treatment. The first patent, titled "Anti-Her2 Nanobody and Coding Sequence and Use Thereof," provides a detailed description of a nanobody specifically designed to combat Her2 positive tumors. This invention includes a gene sequence encoding the nanobody and outlines the methods for producing and utilizing the nanobody as well as its application in immunoconjugates for therapeutic and diagnostic purposes.
The second patent, "Use of Radiolabeled Nanobody in Prognosis and Diagnosis of Cancer," reveals an immunoconjugate that utilizes a radiolabeled anti-PD-L1 nanobody. This invention is designed for non-invasive detection of PD-L1 molecules in tumors, making it a powerful tool for prognosis and diagnosis. Its unique features include high specificity, small size, and suitability for detecting both primary and metastatic tumors, ensuring a lower radiation dose for patients.
Career Highlights
Chung Lim Wong is currently associated with Nanomab Technology Limited, a company that focuses on advancing nanobody technology for healthcare applications. His work significantly impacts the field of oncology, as he explores innovative methods to enhance cancer treatment and diagnosis.
Collaborations
Wong collaborates with talented coworkers such as Hong Hoi Ting and Wenhua Huang, contributing to a dynamic team dedicated to pushing the boundaries of medical innovation through their joint expertise in nanotechnology and oncology.
Conclusion
Chung Lim Wong’s innovative contributions to cancer treatment through his patents highlight the importance of research and collaboration in advancing medical science. As he continues to develop novel approaches for diagnosis and therapy, Wong’s work promises to make a significant impact on the future of oncology, benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile